Discordant sexual identity in some genetic males with cloacal exstrophy assigned to female sex at birth.[N Engl J Med. 2004]

Reiner WG, Gearhart JP

N Engl J Med. 2004 Jan 22; 350(4):333-41.
Review Gender identity outcome in female-raised 46,XY persons with penile agenesis, cloacal exstrophy of the bladder, or penile ablation.[Arch Sex Behav. 2005]

Meyer-Bahlburg HF

Arch Sex Behav. 2005 Aug; 34(4):423-38.
A sex difference in the human brain and its relation to transsexuality.[Nature. 1995]

Zhou JN, Hofman MA, Gooren LJ, Swaab DF

Nature. 1995 Nov 2; 378(6552):68-70.
Transgender health in Massachusetts: results from a household probability sample of adults.[Am J Public Health. 2012]

Conron KJ, Scott G, Stowell GS, Landers SJ

Am J Public Health. 2012 Jan; 102(1):118-22.

Endocrine treatment of transsexual persons: extensive personal experience.[Endocr Pract. 2013]

Leinung MC, Urizar MF, Patel N, Sood SC

Endocr Pract. 2013 Jul-Aug; 19(4):644-50.

Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline.[J Clin Endocrinol Metab. 2009]

Hembree WC, Cohen-Kettenis P, Delemarre-van de Waal HA, Gooren LJ, Meyer WJ 3rd, Spack NP, Tangpricha V, Montori VM, Endocrine Society.

J Clin Endocrinol Metab. 2009 Sep; 94(9):3132-54.

Review Progress on the road to better medical care for transgender patients.[Curr Opin Endocrinol Diabetes Obes. 2013]

Gardner IH, Safer JD

Curr Opin Endocrinol Diabetes Obes. 2013 Dec; 20(6):553-8.
Dose-response analysis of testosterone replacement therapy in patients with female to male gender identity disorder.[Endocr J. 2013]

Nakamura A, Watanabe M, Sugimoto M, Sako T, Mahmood S, Kaku H, Nasu Y, Ishii K, Nagai A, Kumon H

Endocr J. 2013; 60(3):275-81.

Effects of sex steroid deprivation/administration on hair growth and skin sebum production in transsexual males and females.[J Clin Endocrinol Metab. 2000]

Giltay EJ, Gooren LJ

J Clin Endocrinol Metab. 2000 Aug; 85(8):2913-21.
Endocrine treatment of male-to-female transsexuals using gonadotropin-releasing hormone agonist.[Exp Clin Endocrinol Diabetes. 2005]

Dittrich R, Binder H, Cupisti S, Hoffmann I, Beckmann MW, Mueller A

Exp Clin Endocrinol Diabetes. 2005 Dec; 113(10):586-92.

A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones.[Eur J Endocrinol. 2011]

Asscheman H, Giltay EJ, Megens JA, de Ronde WP, van Trotsenburg MA, Gooren LJ

Eur J Endocrinol. 2011 Apr; 164(4):635-42.
Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline.[J Clin Endocrinol Metab. 2009]

Hembree WC, Cohen-Kettenis P, Delemarre-van de Waal HA, Gooren LJ, Meyer WJ 3rd, Spack NP, Tangpricha V, Montori VM, Endocrine Society.

J Clin Endocrinol Metab. 2009 Sep; 94(9):3132-54.
Effects of high dose oestrogen therapy on circulating inflammatory markers.[Maturitas. 2009]

Wilson R, Spiers A, Ewan J, Johnson P, Jenkins C, Carr S

Maturitas. 2009 Mar 20; 62(3):281-6.

Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline.[J Clin Endocrinol Metab. 2009]

Hembree WC, Cohen-Kettenis P, Delemarre-van de Waal HA, Gooren LJ, Meyer WJ 3rd, Spack NP, Tangpricha V, Montori VM, Endocrine Society.

J Clin Endocrinol Metab. 2009 Sep; 94(9):3132-54.
Review Long-term treatment of transsexuals with cross-sex hormones: extensive personal experience.[J Clin Endocrinol Metab. 2008]

Gooren LJ, Giltay EJ, Bunck MC

J Clin Endocrinol Metab. 2008 Jan; 93(1):19-25.

Effects of sex steroid deprivation/administration on hair growth and skin sebum production in transsexual males and females.[J Clin Endocrinol Metab. 2000]

Giltay EJ, Gooren LJ

J Clin Endocrinol Metab. 2000 Aug; 85(8):2913-21.
Long-term evaluation of cross-sex hormone treatment in transsexual persons.[J Sex Med. 2012]

Wierckx K, Mueller S, Weyers S, Van Caenegem E, Roef G, Heylens G, T'Sjoen G

J Sex Med. 2012 Oct; 9(10):2641-51.
Review Testosterone therapy for transgender men.[Lancet Diabetes Endocrinol. 2017]

Irwig MS

Lancet Diabetes Endocrinol. 2017 Apr; 5(4):301-311.
A prospective study on sexual function and mood in female-to-male transsexuals during testosterone administration and after sex reassignment surgery.[J Sex Marital Ther. 2013]

Costantino A, Cerpolini S, Alvisi S, Morselli PG, Venturoli S, Meriggiola MC

J Sex Marital Ther. 2013; 39(4):321-35.
Review Management of female-to-male transgender persons: medical and surgical management, life expectancy.[Curr Opin Endocrinol Diabetes Obes. 2014]

Gooren LJ

Curr Opin Endocrinol Diabetes Obes. 2014 Jun; 21(3):233-8.

Is hormonal therapy associated with better quality of life in transsexuals? A cross-sectional study.[J Sex Med. 2012]

Gorin-Lazard A, Baumstarck K, Boyer L, Maquigneau A, Gebleux S, Penochet JC, Pringuey D, Albarel F, Morange I, Loundou A, Berbis J, Auquier P, Lançon C, Bonierbale M

J Sex Med. 2012 Feb; 9(2):531-41.
Long-term evaluation of cross-sex hormone treatment in transsexual persons.[J Sex Med. 2012]

Wierckx K, Mueller S, Weyers S, Van Caenegem E, Roef G, Heylens G, T'Sjoen G

J Sex Med. 2012 Oct; 9(10):2641-51.
A prospective study on sexual function and mood in female-to-male transsexuals during testosterone administration and after sex reassignment surgery.[J Sex Marital Ther. 2013]

Costantino A, Cerpolini S, Alvisi S, Morselli PG, Venturoli S, Meriggiola MC

J Sex Marital Ther. 2013; 39(4):321-35.
High-Dose Testosterone Treatment Increases Serotonin Transporter Binding in Transgender People.[Biol Psychiatry. 2015]

Kranz GS, Wadsak W, Kaufmann U, Savli M, Baldinger P, Gryglewski G, Haeusler D, Spies M, Mitterhauser M, Kasper S, Lanzenberger R

Biol Psychiatry. 2015 Oct 15; 78(8):525-33.
Review Neuroreceptor imaging in depression.[Neurobiol Dis. 2013]

Savitz JB, Drevets WC

Neurobiol Dis. 2013 Apr; 52():49-65.

Hormonal treatment reduces psychobiological distress in gender identity disorder, independently of the attachment style.[J Sex Med. 2013]

Colizzi M, Costa R, Pace V, Todarello O

J Sex Med. 2013 Dec; 10(12):3049-58.

Review Skeletal sexual dimorphism: relative contribution of sex steroids, GH-IGF1, and mechanical loading.[J Endocrinol. 2010]

Callewaert F, Sinnesael M, Gielen E, Boonen S, Vanderschueren D

J Endocrinol. 2010 Nov; 207(2):127-34.
Bone mass, bone geometry, and body composition in female-to-male transsexual persons after long-term cross-sex hormonal therapy.[J Clin Endocrinol Metab. 2012]

Van Caenegem E, Wierckx K, Taes Y, Dedecker D, Van de Peer F, Toye K, Kaufman JM, T'Sjoen G

J Clin Endocrinol Metab. 2012 Jul; 97(7):2503-11.
Body composition and bone mineral density in male-to-female transsexuals during cross-sex hormone therapy using gonadotrophin-releasing hormone agonist.[Exp Clin Endocrinol Diabetes. 2011]

Mueller A, Zollver H, Kronawitter D, Oppelt PG, Claassen T, Hoffmann I, Beckmann MW, Dittrich R

Exp Clin Endocrinol Diabetes. 2011 Feb; 119(2):95-100.

Review Men and women, so different, so similar: observations from cross-sex hormone treatment of transsexual subjects.[Andrologia. 2014]

Gooren LJ, Giltay EJ

Andrologia. 2014 Jun; 46(5):570-5.
Long-term evaluation of cross-sex hormone treatment in transsexual persons.[J Sex Med. 2012]

Wierckx K, Mueller S, Weyers S, Van Caenegem E, Roef G, Heylens G, T'Sjoen G

J Sex Med. 2012 Oct; 9(10):2641-51.
Sexual desire in female-to-male transsexual persons: exploration of the role of testosterone administration.[Eur J Endocrinol. 2011]

Wierckx K, Elaut E, Van Caenegem E, Van De Peer F, Dedecker D, Van Houdenhove E, T'Sjoen G

Eur J Endocrinol. 2011 Aug; 165(2):331-7.
Review Venous thrombo-embolism as a complication of cross-sex hormone treatment of male-to-female transsexual subjects: a review.[Andrologia. 2014]

Asscheman H, T'Sjoen G, Lemaire A, Mas M, Meriggiola MC, Mueller A, Kuhn A, Dhejne C, Morel-Journel N, Gooren LJ

Andrologia. 2014 Sep; 46(7):791-5.

Review Venous thrombo-embolism as a complication of cross-sex hormone treatment of male-to-female transsexual subjects: a review.[Andrologia. 2014]

Asscheman H, T'Sjoen G, Lemaire A, Mas M, Meriggiola MC, Mueller A, Kuhn A, Dhejne C, Morel-Journel N, Gooren LJ

Andrologia. 2014 Sep; 46(7):791-5.
Management of transgenderism.[JAMA. 2013]

Spack NP

JAMA. 2013 Feb 6; 309(5):478-84.
Prevalence of cardiovascular disease and cancer during cross-sex hormone therapy in a large cohort of trans persons: a case-control study.[Eur J Endocrinol. 2013]

Wierckx K, Elaut E, Declercq E, Heylens G, De Cuypere G, Taes Y, Kaufman JM, T'Sjoen G

Eur J Endocrinol. 2013 Oct; 169(4):471-8.

Interpreting laboratory results in transgender patients on hormone therapy.[Am J Med. 2014]

Roberts TK, Kraft CS, French D, Ji W, Wu AH, Tangpricha V, Fantz CR

Am J Med. 2014 Feb; 127(2):159-62.

Stigma, mental health, and resilience in an online sample of the US transgender population.[Am J Public Health. 2013]

Bockting WO, Miner MH, Swinburne Romine RE, Hamilton A, Coleman E

Am J Public Health. 2013 May; 103(5):943-51.

Health care utilization, barriers to care, and hormone usage among male-to-female transgender persons in New York City.[Am J Public Health. 2009]

Sanchez NF, Sanchez JP, Danoff A

Am J Public Health. 2009 Apr; 99(4):713-9.
People with gender dysphoria who self-prescribe cross-sex hormones: prevalence, sources, and side effects knowledge.[J Sex Med. 2014]

Mepham N, Bouman WP, Arcelus J, Hayter M, Wylie KR

J Sex Med. 2014 Dec; 11(12):2995-3001.
Non-Prescribed Hormone Use and Barriers to Care for Transgender Women in San Francisco.[LGBT Health. 2015]

de Haan G, Santos GM, Arayasirikul S, Raymond HF

LGBT Health. 2015 Dec; 2(4):313-23.

Save items

Similar articles in PubMed

Cited by other articles in PMC

Links

Recent Activity